易缺失的HLA I类等位基因影响获得性再生障碍性贫血早期造血细胞移植的结局
基于日本875例获得性再生障碍性贫血患者的登记数据,分析易缺失HLA I类等位基因对造血细胞移植结局的影响。在诊断后1年内接受移植的399例患者中,HLA关联显著。五种最易缺失的等位基因组合(HLA-A*02:01、A*02:06、A*31:01、B*40:02、B*54:01)与移植后生存最强相关(5年生存率80.3% vs 54.4%,p<0.0001)。另一组等位基因与移植后淋巴增殖性疾病风险增加相关(5年发生率10.2% vs 1.8%,p=0.00019)。
要点
- 在诊断后1年内接受移植的399例患者中,HLA关联显著,与HLA缺失在该组占主导一致。
- 五种最易缺失的HLA等位基因组合是最强移植后生存预测因子(5年生存率80.3% vs 54.4%,p<0.0001)。
- 另一组等位基因与移植后淋巴增殖性疾病风险增加相关(5年发生率10.2% vs 1.8%,p=0.00019)。
核心结论
- 特定的HLA I类等位基因及其潜在缺失显著影响获得性再生障碍性贫血的造血细胞移植结局。
研究设计与样本
- 使用日本875例获得性再生障碍性贫血患者的登记数据进行研究。
主要发现
- HLA关联仅在诊断后1年内接受移植的399例患者中显著,与HLA缺失在该组占主导一致。
- 五种最易缺失的HLA等位基因组合(HLA-A*02:01、A*02:06、A*31:01、B*40:02、B*54:01)是所有可能等位基因组合中最强的移植后生存预测因子(5年生存率80.3% vs 54.4%,p<0.0001),部分由于植入改善和移植前状况改善。
- 另一组等位基因(HLA-A*33:03、B*07:02、B*44:03、B*52:01、B*54:01)在再生障碍性贫血中较少缺失且在外源性EBV相关疾病中代表性不足,与移植后淋巴增殖性疾病风险增加相关(5年发生率10.2% vs 1.8%,p=0.00019)。
- 这些关联由受者而非供者HLA决定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HLA class I allele loss in acquired aplastic anemia (AA) represents an immune escape from the T cell-mediated pathogenesis. We investigated the impact of loss-prone HLA alleles on the hematopoietic cell transplantation (HCT) outcomes using registry data of 875 Japanese patients with acquired AA. HLA associations were evident exclusively among 399 patients who received HCT within 1 year of the diagnosis, consistent with the predominance of HLA loss in this group. A set of five HLA alleles with the highest propensity for loss (HLA-A*02:01, HLA-A*02:06, HLA-A*31:01, HLA-B*40:02, and HLA-B*54:01) was the strongest predictor of post-transplant survival among all possible allele combinations (5-year survival, 80.3% vs. 54.4%; p < 0.0001), partly due to improved engraftment and pre-transplant conditions. Another set (HLA-A*33:03, HLA-B*07:02, HLA-B*44:03, HLA-B*52:01, and HLA-B*54:01)-less frequently lost in AA and underrepresented in Epstein-Barr virus (EBV)-related diseases outside AA-was associated with an increased risk of post-transplant lymphoproliferative disorders (5-year incidence, 10.2% vs. 1.8%; p = 0.00019), suggesting that the loss of protective alleles against EBV during AA pathogenesis may predispose to EBV-driven lymphoproliferations. These associations were determined by recipient, not donor, HLA. Therefore, specific HLA class I alleles and their potential loss significantly influence the HCT outcomes in acquired AA.
引用
- Zaimoku Y, Yamazaki H, Kanaya M, et al. Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia. Am J Hematol. 2025. PMID: 40910546. doi:10.1002/ajh.70054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。